A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease
NCT05343364
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux
Interventions
DRUG:
Vonoprazan
Sponsor
Phathom Pharmaceuticals, Inc.